SE462420B - Anvaendning av trans-2-(1-pyrrolidinyl)-cyklohexylestern av 3-n-pentyloxikarbanilsyra foer framstaellning av ett laekemedel med magsaarslaekande verkan - Google Patents
Anvaendning av trans-2-(1-pyrrolidinyl)-cyklohexylestern av 3-n-pentyloxikarbanilsyra foer framstaellning av ett laekemedel med magsaarslaekande verkanInfo
- Publication number
- SE462420B SE462420B SE8304818A SE8304818A SE462420B SE 462420 B SE462420 B SE 462420B SE 8304818 A SE8304818 A SE 8304818A SE 8304818 A SE8304818 A SE 8304818A SE 462420 B SE462420 B SE 462420B
- Authority
- SE
- Sweden
- Prior art keywords
- effect
- trans
- acid
- pyrrolidinyl
- application
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19833333008 DE3333008A1 (de) | 1983-09-13 | 1983-09-13 | Pharmazeutische mittel mit antiulceroeser, spasmolytischer und lokalanaesthetischer wirkung |
Publications (3)
Publication Number | Publication Date |
---|---|
SE8304818D0 SE8304818D0 (sv) | 1983-09-08 |
SE8304818L SE8304818L (sv) | 1985-03-09 |
SE462420B true SE462420B (sv) | 1990-06-25 |
Family
ID=6208945
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE8304818A SE462420B (sv) | 1983-09-13 | 1983-09-08 | Anvaendning av trans-2-(1-pyrrolidinyl)-cyklohexylestern av 3-n-pentyloxikarbanilsyra foer framstaellning av ett laekemedel med magsaarslaekande verkan |
Country Status (6)
Country | Link |
---|---|
JP (1) | JPS6067421A (fr) |
BE (1) | BE897823A (fr) |
CH (1) | CH654743A5 (fr) |
DE (1) | DE3333008A1 (fr) |
NL (1) | NL8303098A (fr) |
SE (1) | SE462420B (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6103380A (en) | 1998-06-03 | 2000-08-15 | Cabot Corporation | Particle having an attached halide group and methods of making the same |
-
1983
- 1983-08-31 CH CH4782/83A patent/CH654743A5/de not_active IP Right Cessation
- 1983-09-07 NL NL8303098A patent/NL8303098A/nl not_active Application Discontinuation
- 1983-09-08 SE SE8304818A patent/SE462420B/sv not_active IP Right Cessation
- 1983-09-13 DE DE19833333008 patent/DE3333008A1/de active Granted
- 1983-09-19 JP JP58171407A patent/JPS6067421A/ja active Granted
- 1983-09-26 BE BE0/211577A patent/BE897823A/fr not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
SE8304818L (sv) | 1985-03-09 |
JPS6067421A (ja) | 1985-04-17 |
DE3333008A1 (de) | 1985-03-21 |
NL8303098A (nl) | 1985-04-01 |
JPH045003B2 (fr) | 1992-01-30 |
SE8304818D0 (sv) | 1983-09-08 |
BE897823A (fr) | 1984-01-16 |
DE3333008C2 (fr) | 1990-06-21 |
CH654743A5 (en) | 1986-03-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU638493B2 (en) | Preparations containing colestyramine for reducing lipid levels | |
AU5379796A (en) | Pharmaceutical composition containing proton pump inhibitors | |
JP5538386B2 (ja) | フェルラ酸とマトリン類化合物を含有する薬物組成物及びその製造方法と用途 | |
TW304167B (fr) | ||
JP2022542304A (ja) | ブルシンゲル製剤及びその製造方法 | |
US4973596A (en) | Method of administering a narcotic analgesic and dosage forms therefor | |
SE462420B (sv) | Anvaendning av trans-2-(1-pyrrolidinyl)-cyklohexylestern av 3-n-pentyloxikarbanilsyra foer framstaellning av ett laekemedel med magsaarslaekande verkan | |
JPH09500121A (ja) | 痴呆症の治療のためのナブメトンまたは6−メトキシナフチル酢酸の使用 | |
CN111789832B (zh) | 右酮洛芬氨丁三醇凝胶贴膏及其制备方法 | |
EP2606883A1 (fr) | Utilisations de n-butylidenephthalide dans le traitement d'une lésion du foie et amélioration de la fonction hépatique | |
JP6178058B2 (ja) | 抗炎症及び/又は抗ヒスタミン剤組成物 | |
CN112691102A (zh) | 黄芩素在防治帕金森病/帕金森综合征抑郁症状中的应用 | |
JP2010241834A (ja) | 医薬組成物 | |
CN106507666A9 (zh) | 1,3‑丙二磺酸或其药学上可接受的盐用于治疗肉样瘤病的用途 | |
JP2938579B2 (ja) | 消化管壁保護剤 | |
Mohamed et al. | Preparation and release characteristics of Itracinazole poymeric films for topical application | |
US4348407A (en) | Orally active tolciclate and tolnaftate | |
CN105663152A (zh) | 三乙酰基-3-羟基苯基腺苷在制备改善胰岛素抵抗及相关疾病中的应用 | |
CN111084779A (zh) | 白头翁皂苷b4的新用途 | |
JP5389471B2 (ja) | 鼻閉抑制剤 | |
JP2006008540A (ja) | 風邪薬 | |
WO2019242764A1 (fr) | Application de glycosides dans la préparation de médicaments pour la prévention et le traitement de complications du diabète | |
BR202020007803U2 (pt) | Sistema para administração de formulações orais em animais de médio e grande porte | |
CA3232946A1 (fr) | Composition pharmaceutique pour la prevention ou le traitement de la maladie d'alzheimer | |
CN114903910A (zh) | 芹菜素-7-O-β-D-葡萄糖苷在制备炎症性肠病治疗药物中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NAL | Patent in force |
Ref document number: 8304818-1 Format of ref document f/p: F |
|
NUG | Patent has lapsed |
Ref document number: 8304818-1 Format of ref document f/p: F |